Guk-Hyun Hwang
Chief Executive Officer at BELLEVUE LIFE SCIENCES ACQUISITION CORP.
Net worth: 14 M $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jin Park | M | 56 |
Korea University
| 6 years |
| Ralf Kubli | M | - |
BCM Europe AG
 BCM Europe AG Investment ManagersFinance BCM Europe AG provides investment and financial advisory services. The private company is based in Zug, Switzerland and has subsidiaries in Switzerland. Guk-Hyun Hwang has been the CEO of the Swiss company since 2020.
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | - |
| Jun Chul Whang | M | 59 |
Bellevue Capital Management LLC
| 9 years |
| Young-Soo Yoon | M | - |
Korea University
| 27 years |
| Jin Yoo | M | 50 | 3 years | |
| Ick-Soo Kim | M | 68 |
Korea University
| 29 years |
| Eon-Soo Kim | M | 62 |
Korea University
| 29 years |
| Peter Hwang | M | - |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | - |
| Sung-Jae Yu | M | - |
OSR Holdings Co., Ltd.
 OSR Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology OSR Holdings Co., Ltd. is a South Korean healthcare company that develops and licenses innovative biomedical therapies based on proprietary platform technologies to address unmet medical needs. The private company is based in an undisclosed location. The company wholly-owns three operating subsidiaries focused on developing therapeutic drugs in the areas of oncology and osteoarthritis, and the third is a distributor of medical devices for the treatment of neurovascular and other diseases. OSR Holdings signed a letter of intent to acquire Landmark Bioventures AG, a Swiss company that operates through four different biotech ventures with therapeutic focuses on oncology and immunology. The company was founded in 2019, and the CEO is Sean Chung. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Steven Reed | M | 73 | 1 years | |
| Min-Su Jeong | M | 53 |
Korea University
| 6 years |
| Hosun Euh | M | 46 | - | |
| Radclyffe Roberts | M | 56 | 1 years | |
| Heinz Lubenau | M | - |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | 14 years |
| In-Chul Chung | M | 60 | 1 years | |
| Bo-Eun Kim | M | 55 |
Korea University
| 3 years |
| Tae Yang Shin | M | 46 |
Korea University
| 7 years |
| Sung Sik Byun | M | - |
Korea University
| 8 years |
| ChongMook Kang | M | - |
Korea University
| 8 years |
| Jean Rok Han | M | - |
Korea University
| 6 years |
| Sung-Sup Ki | M | 74 |
Korea University
| 1 years |
| Chan-Wha Park | M | 63 |
Korea University
| 2 years |
| Kyo-Hwa Chung | F | 51 |
Korea University
| 3 years |
| Min Hyun Shim | M | - |
Korea University
| 7 years |
| Wonbae Lee | M | 51 |
Korea University
| 4 years |
| Young Soo Lee | M | - |
Korea University
| 4 years |
| Sang-Soo Kim | M | - |
Korea University
| 8 years |
| Sook-Kwon Yong | M | - |
Korea University
| 3 years |
| Gil-Jae Ryoo | M | 65 |
Korea University
| 7 years |
| Cha-Kyoon Koo | M | 66 |
Korea University
| - |
| Sang-Jick Yoon | M | 68 |
Korea University
| 1 years |
| Seong-Mo Jeong | M | - |
Korea University
| 7 years |
| Jae-Bum Jung | M | - |
Korea University
| 1 years |
| Bang Seon Ko | M | 55 |
Korea University
| 4 years |
| Min-Sik Park | M | - |
Korea University
| 4 years |
| One-Il Kim | M | 49 |
Korea University
| 4 years |
| Ju-Heon Lee | M | 51 |
Korea University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| South Korea | 28 | 75.68% |
| United States | 7 | 18.92% |
| Switzerland | 3 | 8.11% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Guk-Hyun Hwang
- Personal Network
